THA Clinical Trials

299 recruitingLast updated: July 25, 2026

There are 299 actively recruiting tha clinical trials across 58 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1, Early Phase 1. Top locations include New York, New York, United States, Houston, Texas, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


THA Trials at a Glance

299 actively recruiting trials for tha are listed on ClinicalTrialsFinder across 6 cities in 58 countries. The largest study group is Not Applicable with 84 trials, with the heaviest enrollment activity in New York, Houston, and Boston. Lead sponsors running tha studies include Shanghai Changzheng Hospital, Institute of Hematology & Blood Diseases Hospital, China, and Cairo University.

Treatments under study

About THA Clinical Trials

Looking for clinical trials for THA? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new THA trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about THA clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 299 trials

Recruiting
Phase 2

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

Unresectable or Metastatic Hepatocellular CarcinomaChild-Pugh A Hepatocellular CarcinomaFailure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound
CatalYm GmbH104 enrolled14 locationsNCT07219459
Recruiting

Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC)

AnophthalmiaMicrophthalmiaColoboma
National Eye Institute (NEI)600 enrolled1 locationNCT01778543
Recruiting
Early Phase 1

Bimatoprost as a Treatment for Graves' Orbitopathy

Graves Ophthalmopathy
Johns Hopkins University3 enrolled1 locationNCT03708627
Recruiting
Phase 2

Role of Estrogen on Skeletal Outcomes in FHA

Bone DensityFHA (Functional Hypothalamic Amenorrhea)Bone Strength
University of Virginia150 enrolled2 locationsNCT07010146
Recruiting
Phase 2

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

GerminomaBasal Ganglia GerminomaDiabetes Insipidus+3 more
Children's Oncology Group240 enrolled114 locationsNCT06368817
Recruiting
Not Applicable

Randomized Controlled Trial Testing a Training Program About Section 504 of the Rehabilitation Act

Students With Disabilities and/or Family Members With Students With Disabilities That Have a Section 504 Plan
Vanderbilt University160 enrolled1 locationNCT07710300
Recruiting
Phase 2

A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea

Functional Hypothalamic Amenorrhea (FHA)
Regeneron Pharmaceuticals34 enrolled10 locationsNCT07235917
Recruiting
Not Applicable

Two Intravenous Doses of Ketamine in Reducing the Oculocardiac Reflex in Adult Patients Undergoing Ophthalmic Surgery

KetamineOphthalmic SurgeryOculocardiac Reflex
Cairo University40 enrolled1 locationNCT07708740
Recruiting
Phase 1Phase 2

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

Advanced Solid Tumors That Are MTAP Deficient
AstraZeneca334 enrolled21 locationsNCT06130553
Recruiting
Phase 1Phase 2

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Beta-ThalassemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI)90 enrolled1 locationNCT07599176
Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

ThrombophiliaThrombosisSickle Cell Disease+10 more
American Thrombosis and Hemostasis Network3,000 enrolled71 locationsNCT04398628
Recruiting

Hertel Exophthalmometry Values in Mexican Adults

ExophthalmometryNormal Exophthalmometric Values
Instituto de Oftalmología Fundación Conde de Valenciana300 enrolled1 locationNCT07705061
Recruiting
Phase 2

Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea

Hypogonadotropic HypogonadismHypothalamic Amenorrhea
Stephanie B. Seminara, MD20 enrolled1 locationNCT07224438
Recruiting
Not Applicable

Clinical Outcomes Study of the Nexel Total Elbow

Degenerative ArthritisElbow Joint DestructionPost-traumatic Lesions+7 more
Zimmer Biomet134 enrolled11 locationsNCT02469662
Recruiting

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Sickle Cell DiseaseMalariaAlpha and Beta Thalassemia+1 more
National Institute of Allergy and Infectious Diseases (NIAID)300 enrolled1 locationNCT03937817
Recruiting
Phase 2

Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

Beta-Thalassemia
Celgene99 enrolled26 locationsNCT04143724
Recruiting
Not Applicable

Wound Healing, Dressing Type, and Dressing Change Frequency in THA

Total Hip Arthroplasty (THA)Wound Healing Time
Clinical Center of Vojvodina90 enrolled1 locationNCT07655388
Recruiting
Phase 2

A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

methamphetamine abuseMethamphetamine DisordersMethamphetamine Intoxication
Clear Scientific, Inc.40 enrolled1 locationNCT06721494
Recruiting
Phase 1

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

Sickle Cell DiseaseHb-SS DiseaseHemoglobin S+3 more
National Heart, Lung, and Blood Institute (NHLBI)25 enrolled1 locationNCT05904093
Recruiting

National Cohort on Congenital Defects of the Eye

AniridiaAnophthalmiaMicrophthalmia+2 more
Institut National de la Santé Et de la Recherche Médicale, France800 enrolled1 locationNCT05954403